Sketris I - Search Results

1

Administrative claims data analysis of nurse practitioner prescribing for older adults.

Murphy AL, Martin-Misener R, Cooke C, Sketris I. Murphy AL, et al. Among authors: sketris i. J Adv Nurs. 2009 Oct;65(10):2077-87. doi: 10.1111/j.1365-2648.2009.05069.x. J Adv Nurs. 2009. PMID: 19674174

2

Prescribing patterns of antilipemic drugs and prevalence of hypercholesterolemia in the Nova Scotia population more than 65 years old.

Sketris IS, Kephart GC, Hicks VA, Hubbard EJ, Brown MG, Chandler RF, MacLean DR. Sketris IS, et al. Ann Pharmacother. 1995 Jun;29(6):576-81. doi: 10.1177/106002809502900604. Ann Pharmacother. 1995. PMID: 7663028

3

Coprescribing of nonsteroidal anti-inflammatory drugs and cytoprotective and antiulcer drugs in Nova Scotia's senior population.

Kephart G, Sketris I, Smith M, Maheu A, Brown M. Kephart G, et al. Among authors: sketris i. Clin Ther. 1995 Nov-Dec;17(6):1159-73. doi: 10.1016/0149-2918(95)80095-6. Clin Ther. 1995. PMID: 8750407

4

Impact of a limited fluoroquinolone reimbursement policy on antimicrobial prescription claims.

MacCara ME, Sketris IS, Comeau DG, Weerasinghe SD. MacCara ME, et al. Among authors: sketris is. Ann Pharmacother. 2001 Jul-Aug;35(7-8):852-8. doi: 10.1345/aph.10272. Ann Pharmacother. 2001. PMID: 11485132

5

Physician characteristics in relation to cardiovascular drugs commonly prescribed for hypertension in Nova Scotia.

Burge F, Kephart G, Flowerdew G, Putnam W, Comeau DG, Whelan AM, Sketris I, Sclar D. Burge F, et al. Among authors: sketris i. Can J Clin Pharmacol. 2001 Fall;8(3):139-45. Can J Clin Pharmacol. 2001. PMID: 11574896

6

Evaluation of the use of evidence-based angiotensin-converting enzyme inhibitor criteria for the treatment of congestive heart failure: opportunities for pharmacists to improve patient outcomes.

Pearson GJ, Cooke C, Simmons WK, Sketris I. Pearson GJ, et al. Among authors: sketris i. J Clin Pharm Ther. 2001 Oct;26(5):351-61. doi: 10.1046/j.1365-2710.2001.00364.x. J Clin Pharm Ther. 2001. PMID: 11679025

7

Trends in oral antihyperglycemic and insulin use in the Nova Scotia senior population (1993-1999).

Morningstar BA, Sketris IS, Kephart GC, Sclar DA. Morningstar BA, et al. Can J Clin Pharmacol. 2002 Fall;9(3):123-9. Can J Clin Pharmacol. 2002. PMID: 12422249

8

Topical corticosteroid prescribing patterns following changes in drug benefit status.

Campbell CA, Cooke CA, Weerasinghe SD, Sketris IS, McLean-Veysey PR, Skedgel CD. Campbell CA, et al. Ann Pharmacother. 2003 Jun;37(6):787-93. doi: 10.1345/aph.1C196. Ann Pharmacother. 2003. PMID: 12773062

9

Policy choices for pharmacare; the need to examine benefit design, medication management strategies and evaluation.

Sketris IS, Brown MG, Murphy AL. Sketris IS, et al. Healthc Pap. 2004;4(3):36-45; discussion 68-72. doi: 10.12927/hcpap..16875. Healthc Pap. 2004. PMID: 15114068

10

The effect of deinsuring chlorpropamide on the prescribing of oral antihyperglycemics for Nova Scotia Seniors' Pharmacare beneficiaries.

Sketris IS, Kephart GC, Frail DM, Skedgel C, Allen MJ. Sketris IS, et al. Pharmacotherapy. 2004 Jun;24(6):784-91. doi: 10.1592/phco.24.8.784.36073. Pharmacotherapy. 2004. PMID: 15222669

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters